S&P 500   4,507.84 (+0.48%)
DOW   35,385.49 (+0.36%)
QQQ   373.97 (+0.35%)
AAPL   148.27 (+1.17%)
MSFT   308.39 (+0.36%)
FB   338.44 (+0.92%)
GOOGL   2,856.59 (+0.04%)
TSLA   868.93 (-0.14%)
AMZN   3,434.66 (-0.35%)
NVDA   221.27 (-0.43%)
BABA   172.46 (+3.38%)
NIO   39.91 (+0.76%)
CGC   13.42 (+1.67%)
GE   104.26 (+0.13%)
AMD   115.29 (-0.98%)
MU   66.98 (-0.42%)
T   25.41 (+0.32%)
F   15.55 (-0.06%)
ACB   6.97 (+0.72%)
DIS   170.45 (-0.40%)
PFE   41.90 (+1.40%)
BA   216.01 (-0.45%)
AMC   43.31 (+0.65%)
S&P 500   4,507.84 (+0.48%)
DOW   35,385.49 (+0.36%)
QQQ   373.97 (+0.35%)
AAPL   148.27 (+1.17%)
MSFT   308.39 (+0.36%)
FB   338.44 (+0.92%)
GOOGL   2,856.59 (+0.04%)
TSLA   868.93 (-0.14%)
AMZN   3,434.66 (-0.35%)
NVDA   221.27 (-0.43%)
BABA   172.46 (+3.38%)
NIO   39.91 (+0.76%)
CGC   13.42 (+1.67%)
GE   104.26 (+0.13%)
AMD   115.29 (-0.98%)
MU   66.98 (-0.42%)
T   25.41 (+0.32%)
F   15.55 (-0.06%)
ACB   6.97 (+0.72%)
DIS   170.45 (-0.40%)
PFE   41.90 (+1.40%)
BA   216.01 (-0.45%)
AMC   43.31 (+0.65%)
S&P 500   4,507.84 (+0.48%)
DOW   35,385.49 (+0.36%)
QQQ   373.97 (+0.35%)
AAPL   148.27 (+1.17%)
MSFT   308.39 (+0.36%)
FB   338.44 (+0.92%)
GOOGL   2,856.59 (+0.04%)
TSLA   868.93 (-0.14%)
AMZN   3,434.66 (-0.35%)
NVDA   221.27 (-0.43%)
BABA   172.46 (+3.38%)
NIO   39.91 (+0.76%)
CGC   13.42 (+1.67%)
GE   104.26 (+0.13%)
AMD   115.29 (-0.98%)
MU   66.98 (-0.42%)
T   25.41 (+0.32%)
F   15.55 (-0.06%)
ACB   6.97 (+0.72%)
DIS   170.45 (-0.40%)
PFE   41.90 (+1.40%)
BA   216.01 (-0.45%)
AMC   43.31 (+0.65%)
S&P 500   4,507.84 (+0.48%)
DOW   35,385.49 (+0.36%)
QQQ   373.97 (+0.35%)
AAPL   148.27 (+1.17%)
MSFT   308.39 (+0.36%)
FB   338.44 (+0.92%)
GOOGL   2,856.59 (+0.04%)
TSLA   868.93 (-0.14%)
AMZN   3,434.66 (-0.35%)
NVDA   221.27 (-0.43%)
BABA   172.46 (+3.38%)
NIO   39.91 (+0.76%)
CGC   13.42 (+1.67%)
GE   104.26 (+0.13%)
AMD   115.29 (-0.98%)
MU   66.98 (-0.42%)
T   25.41 (+0.32%)
F   15.55 (-0.06%)
ACB   6.97 (+0.72%)
DIS   170.45 (-0.40%)
PFE   41.90 (+1.40%)
BA   216.01 (-0.45%)
AMC   43.31 (+0.65%)
OTCMKTS:AOLS

Aeolus Pharmaceuticals Stock Forecast, Price & News

$0.0008
0.00 (0.00 %)
(As of 10/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
$0.02
VolumeN/A
Average Volume412,672 shs
Market Capitalization$108,744.00
P/E RatioN/A
Dividend YieldN/A
Beta2.33
30 days | 90 days | 365 days | Advanced Chart
Receive AOLS News and Ratings via Email

Sign-up to receive the latest news and ratings for Aeolus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.


About Aeolus Pharmaceuticals

Aeolus Pharmaceuticals, Inc. engages in the development of a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease, and diseases of the central nervous system. The company was founded by Brian J. Day in 1994 and is headquartered in Mission Viejo, CA.

Headlines

Aeolus Pharmaceuticals Inc.
September 1, 2020 |  barrons.com
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:AOLS
Employees
4
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$108,744.00
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.13 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Aeolus Pharmaceuticals (OTCMKTS:AOLS) Frequently Asked Questions

What stocks does MarketBeat like better than Aeolus Pharmaceuticals?

Wall Street analysts have given Aeolus Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aeolus Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Aeolus Pharmaceuticals' earnings last quarter?

Aeolus Pharmaceuticals, Inc. (OTCMKTS:AOLS) posted its quarterly earnings results on Monday, August, 14th. The biopharmaceutical company reported ($0.01) earnings per share (EPS) for the quarter. The biopharmaceutical company had revenue of $0.01 million for the quarter.
View Aeolus Pharmaceuticals' earnings history
.

How has Aeolus Pharmaceuticals' stock been impacted by COVID-19?

Aeolus Pharmaceuticals' stock was trading at $0.0010 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, AOLS shares have decreased by 20.0% and is now trading at $0.0008.
View which stocks have been most impacted by COVID-19
.

Who are Aeolus Pharmaceuticals' key executives?

Aeolus Pharmaceuticals' management team includes the following people:
  • John L. McManus, President & Chief Executive Officer

What other stocks do shareholders of Aeolus Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aeolus Pharmaceuticals investors own include iBio (IBIO), Myriad Genetics (MYGN), Synergy Pharmaceuticals (SGYP), Titan Pharmaceuticals (TTNP), ADOMANI (ADOM), Agritek (AGTK), Akers Biosciences (AKER), Argos Therapeutics (ARGSQ), Arena Pharmaceuticals (ARNA) and Biohaven Pharmaceutical (BHVN).

What is Aeolus Pharmaceuticals' stock symbol?

Aeolus Pharmaceuticals trades on the OTCMKTS under the ticker symbol "AOLS."

How do I buy shares of Aeolus Pharmaceuticals?

Shares of AOLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aeolus Pharmaceuticals' stock price today?

One share of AOLS stock can currently be purchased for approximately $0.00.

How much money does Aeolus Pharmaceuticals make?

Aeolus Pharmaceuticals has a market capitalization of $108,744.00.

How many employees does Aeolus Pharmaceuticals have?

Aeolus Pharmaceuticals employs 4 workers across the globe.

What is Aeolus Pharmaceuticals' official website?

The official website for Aeolus Pharmaceuticals is www.aeoluspharma.com.

Where are Aeolus Pharmaceuticals' headquarters?

Aeolus Pharmaceuticals is headquartered at 26361 CROWN VALLEY PARKWAY SUITE 150, MISSION VIEJO CA, 92691.

How can I contact Aeolus Pharmaceuticals?

Aeolus Pharmaceuticals' mailing address is 26361 CROWN VALLEY PARKWAY SUITE 150, MISSION VIEJO CA, 92691. The biopharmaceutical company can be reached via phone at (949) 481-9825 or via email at [email protected].


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.